0
Signin
countryflagUS

18889881171

AAPL 165.84 0.5091% MSFT 400.96 0.461% GOOG 157.95 1.4321% GOOGL 156.28 1.4212% AMZN 177.23 1.4889% NVDA 795.18 4.3543% META 481.73 0.1372% TSLA 142.05 -3.4002% TSM 129.75 1.6053% LLY 731.33 0.6912% V 272.33 0.9452% AVGO 1224.46 1.6394% JPM 189.41 1.9429% UNH 491.23 -1.9755% NVO 125.26 2.0781% WMT 60.14 1.0247% LVMUY 168.89 0.4222% XOM 120.57 0.5756% LVMHF 851.89 0.4528% MA 456.75 0.2986%

Akanda Corp

Healthcare US AKAN

0.0913USD
-0.0031(3.28%)

Last update at 2024-04-22T20:12:00Z

Day Range

0.090.11
LowHigh

52 Week Range

0.404.17
LowHigh

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -8.23545M -8.13120M -2.30057M -1.39464M
Minority interest - - - -
Net income 0.40M -9.22413M -2.94597M -1.88845M
Selling general administrative 19.85M 5.81M 1.36M 0.70M
Selling and marketing expenses - - - -
Gross profit 3.27M -0.71473M 0.00025M 0.00000M
Reconciled depreciation 3.76M 0.31M 0.25M 0.20M
Ebit -20.17639M -6.83373M -1.66583M -0.90124M
Ebitda -16.41152M -6.49790M -1.40654M -0.70201M
Depreciation and amortization 3.76M 0.34M 0.26M 0.20M
Non operating income net other - - - -
Operating income -20.17639M -6.83373M -1.66583M -0.90124M
Other operating expenses 22.80M 6.88M 1.67M 0.90M
Interest expense 0.12M 1.09M 0.65M 0.49M
Tax provision - - - -
Interest income 0.00089M 0.03M 0.01M 0.00040M
Net interest income -0.11444M -1.06613M -0.63497M -1.59341M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -8.63249M 1.09M 0.65M 0.49M
Total revenue 2.62M 0.04M 0.00206M 0.00000M
Total operating expenses 23.45M 6.12M 1.67M 0.90M
Cost of revenue -0.64988M 0.76M 0.00181M 0.00000M
Total other income expense net 11.94M -1.29747M -0.63474M -0.49341M
Discontinued operations -3.42223M -3.42223M -3.42223M -3.42223M
Net income from continuing ops -8.23545M -8.13120M -2.30057M -2.49464M
Net income applicable to common shares -11.65767M -8.13120M -2.30057M -1.39464M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 39.00M 8.05M 4.27M -
Intangible assets 22.21M 0.26M 0.32M -
Earning assets - - - -
Other current assets 0.81M 484886.00M 0.11M -
Total liab 12.10M 10.25M 9.31M -
Total stockholder equity 26.90M -2.20142M -5.03194M -
Deferred long term liab - - - -
Other current liab 1.06M 8268428.00M - -
Common stock 49.43M 7.26M 0.00164M -
Capital stock 49.43M 7.26M 0.00164M -
Retained earnings -21.08796M -13.29389M -5.16269M -
Other liab - - - -
Good will - - - -
Other assets 0.48M - - -
Cash 0.23M 3.50M 0.01M -
Cash and equivalents - - - -
Total current liabilities 9.35M 8.27M 2.73M -
Current deferred revenue - -8268428.00000M - -
Net debt 3.67M 6.07M 9.11M -
Short term debt 1.15M 7.59M 2.55M -
Short long term debt 0.94M 7.15M 2.26M -
Short long term debt total 3.90M 9.57M 9.12M -
Other stockholder equity -1.44657M 11092467.00M 0.13M -
Property plant equipment 12.48M 3.81M 3.83M -
Total current assets 3.82M 3.98M 0.13M -
Long term investments - - - -
Net tangible assets 4.69M -2.46052M -5.35335M -
Short term investments 0.26M - - -
Net receivables 1.24M 0.24M 0.00000M -
Long term debt 2.63M - 3.98M -
Inventory 1.06M -484885.75747M 0.00061M -
Accounts payable 7.14M 0.68M 0.18M -
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income -1.44657M 3.84M 0.13M -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other 0.48M - - -
Deferred long term asset charges - - - -
Non current assets total 35.18M 4.07M 4.15M -
Capital lease obligations 0.33M 2.42M 2.88M -
Long term debt total - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -4.21866M -0.57647M -0.43220M -0.69277M
Change to liabilities 2.92M 0.00000M 0.14M 0.04M
Total cashflows from investing activities -4.21866M -0.57647M -0.43220M -0.69277M
Net borrowings -0.79444M 6.18M 1.03M 2.12M
Total cash from financing activities 14.14M 11.24M 1.03M 2.12M
Change to operating activities -0.64310M 0.37M -0.10984M 0.02M
Net income -11.65767M -8.13120M -2.30057M -1.39464M
Change in cash -3.23959M 3.48M -0.80606M 0.80M
Begin period cash flow 3.50M 0.01M 0.82M 0.02M
End period cash flow 0.26M 3.50M 0.01M 0.82M
Total cash from operating activities -11.46940M -6.55706M -1.35247M -0.64233M
Issuance of capital stock 14.93M 5.05M 0.00148M 0.00000M
Depreciation 3.76M 0.31M 0.25M 0.20M
Other cashflows from investing activities -0.73995M -0.73995M 0.00693M -0.00685M
Dividends paid - - - -
Change to inventory 0.50M -0.71252M -0.00061M -0.00061M
Change to account receivables -0.59107M -0.24236M -0.24236M -0.24236M
Sale purchase of stock - - - -
Other cashflows from financing activities 0.50M 6.68M 1.17M -0.69277M
Change to netincome -5.75785M 1.85M 0.67M 0.49M
Capital expenditures 0.31M 0.58M 0.44M 0.69M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital 2.18M -0.58750M 0.03M 0.06M
Stock based compensation 0.56M - - -
Other non cash items -6.31707M 1.85M 0.67M 0.49M
Free cash flow -11.78034M -7.13353M -1.79160M -1.32825M

Fundamentals

  • Previous Close 0.09
  • Market Cap1.63M
  • Volume7133717
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-16.42438M
  • Revenue TTM2.62M
  • Revenue Per Share TTM0.88
  • Gross Profit TTM 3.27M
  • Diluted EPS TTM-2.8

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AKAN
Akanda Corp		 -0.0031 3.28% 0.09 - - 0.59 0.06 1.89 -1.1387
ZTS
Zoetis Inc		 -0.96 0.66% 145.54 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.30 0.96% 31.39 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.75 1.73% 156.00 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.12 0.91% 13.36 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. The company operates through Cultivation and Distribution segments. It intends to supply medicinal-grade cannabis and cannabis based medical and wellness products. The company was founded in 2018 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

1a, 1b Learoyd Road, New Romney, United Kingdom, TN28 8XU

Key Executives

Name Title Year Born
Ms. Louisa Madiako Mojela B.Com., B.Comm Exec. Chairman 1956
Mr. Tejinder Virk CEO & Director 1982
Mr. Trevor W. Scott BAcc, BCom (Hons), CA(SA) CFO & Sec. 1980
Mr. Thomas Flow Chief Operating Officer 1977

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).